Agilent Opens Center of Excellence for Dissolution Products

SANTA CLARA, Calif., October 12, 2022  Agilent Technologies Inc. (NYSE: A) today announced the opening of the Dissolution Center of Excellence (CoE) facility in Craven Arms, United Kingdom. The newly modernized premises will house the core of Agilent’s dissolution business, including research and development, quality, support, applications, marketing, and more. This investment allows all Agilent dissolution... Read more

Agilent Announces Enhanced 8700 LDIR Chemical Imaging System for Microplastics Analysis

Increased testing capacity will provide greater understanding of microplastics contamination in the environment SANTA CLARA, Calif., October 03, 2022  Agilent Technologies Inc. (NYSE: A) today announced the release of its enhanced 8700 LDIR Chemical Imaging System, which has been further optimized for the analysis of microplastics in environmental samples. This newly improved package includes Clarity 1.5... Read more

Bruker Introduces Enabling New Scientific Capabilities for Cell Biology and Pathobiology Research with High-Field NMR Innovations

Novel NMR Probe Technologies, GHz-class NMR and Dynamics Software Enable New Research, and Advance Functional Structural Biology and Drug Discovery BOSTON–(BUSINESS WIRE)– At the ICMRBS 2022 Conference, Bruker today announces a new 8 mm 15N TROSY Cryoprobe for enabling novel NMR functional structural biology investigations into larger globular proteins and protein complexes. The new technology... Read more

Nanalysis Scientific Corp. Announces Management Transitions

CALGARY, AB, July 21, 2022 /CNW/ – Nanalysis Scientific Corp. (TSXV: NSCI) (OTCQX: NSCIF) (FRA: 1N1) (“Nanalysis” or the “Company”) announces that the current CFO, Luke Caplette, is stepping down as CFO, but will remain with the Company as a part-time consultant to assist the transition to a new CFO. The Company is pleased that its Corporate Controller, Randall McRae, has been... Read more

Bruker Announces Three New GHz NMR Systems Orders for Functional Structural Biology and Clinical Phenomics Research

Three Labs in Japan and Spain to Receive Novel Compact Ascend Evo 1.0 GHz Magnets UTRECHT, The Netherlands–(BUSINESS WIRE)– At the Euromar 2022 Conference, Bruker announced three new customer orders for GHz systems, which will incorporate novel, compact 1.0 GHzNMR magnets for structural biology applications and clinical research in single-story laboratories. The new Ascend Evo... Read more

Bruker Launches NMR-based Molecular Phenomics Clinical Research Tool for ‘Long COVID’ Multi-Organ Risk Assessment

ETTLINGEN, Germany–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today has launched PhenoRiskPACS™ RuO, a research-use-only NMR test for molecular phenomics research on ‘Long COVID’ patients’ blood samples, using a multiplexed combination of biomarkers discovered at the Australian National Phenome Center (ANPC) at Murdoch University, under Director Jeremy Nicholson. The PhenoRiskPACS™ RuO test is promising for research... Read more

Bruker Demonstrates Novel and Unique Compact 1.0 GHz NMR Magnet

New Innovations Support Customers to Reduce Liquid Helium Consumption ORLANDO, Fla.–(BUSINESS WIRE)– At the Experimental Nuclear Magnetic Resonance Conference (ENC 2022), Bruker demonstrates a novel and remarkably compact 1.0 GHz NMR magnet, operating at 4.2 Kelvin, for structural biology applications in single-story standard laboratories. Bruker also offers innovations and services for reducing liquid helium consumption.... Read more